{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:27:44Z","timestamp":1770517664452,"version":"3.49.0"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,2,1]]},"DOI":"10.2169\/internalmedicine.5556-25","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T22:07:45Z","timestamp":1752098865000},"page":"368-378","source":"Crossref","is-referenced-by-count":1,"title":["Utility of MELD 3.0 and MELD-Na in Predicting Long-term Mortality and Rebleeding after Endoscopic Hemostasis for Acute Variceal Hemorrhaging in Patients with Cirrhosis"],"prefix":"10.2169","volume":"65","author":[{"given":"Shinya","family":"Yokoyama","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Ishizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Tsuzuki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toyota Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 362: 823-832, 2010.","DOI":"10.1056\/NEJMra0901512"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; the Baveno VII Faculty. Baveno VII - renewing consensus in portal hypertension. J Hepatol 76: 959-974, 2022.","DOI":"10.1007\/978-3-031-08552-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wang J, Wang AJ, Li BM, et al. MELD-Na effective in predicting rebleeding in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy. J Clin Gastroenterol 48: 870-877, 2014.","DOI":"10.1097\/MCG.0000000000000043"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yokoyama S, Honda T, Ishizu Y, et al. Predicting early rebleeding and mortality after endoscopic hemostasis of esophagogastric varices: diagnostic performance of aspartate aminotransferase-to-platelet ratio index and model for end-stage liver disease-Na score. J Hepatobiliary Pancreat Sci 31: 830-839, 2024.","DOI":"10.1002\/jhbp.12057"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kim WR, Mannalithara A, Heimbach JK, et al. MELD 3.0: the Model for End-Stage Liver disease updated for the modern era. Gastroenterology 161: 1887-1895, 2021.","DOI":"10.1053\/j.gastro.2021.08.050"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 359: 1018-1026, 2008.","DOI":"10.1056\/NEJMoa0801209"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Soresi M, Giannitrapani L, Cervello M, Licata A, Montalto G. Non invasive tools for the diagnosis of liver cirrhosis. World J Gastroenterol 20: 18131-18150, 2014.","DOI":"10.3748\/wjg.v20.i48.18131"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol 76: 681-693, 2022.","DOI":"10.1016\/j.jhep.2021.11.018"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rinella ME, Lazarus JV, Ratziu V, et al.; the NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79: 1542-1556, 2023.","DOI":"10.1097\/HEP.0000000000000696"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K. Endoscopic classification of gastric varices. Gastrointest Endosc 36: 276-280, 1990.","DOI":"10.1016\/S0016-5107(90)71023-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yoshida H, Mamada Y, Taniai N, et al. Treatment modalities for bleeding esophagogastric varices. J Nippon Med Sch 79: 19-30, 2012.","DOI":"10.1272\/jnms.79.19"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Tripathi D, Stanley AJ, Hayes PC, et al. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 64: 1680-1704, 2015.","DOI":"10.1136\/gutjnl-2015-309262"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. de Franchis R; the Braveno VI Faculty. Expanding consensus in portal hypertension report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 63: 743-752, 2015.","DOI":"10.1007\/978-3-319-23018-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. de Franchis R; the Braveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 53: 762-768, 2010.","DOI":"10.1016\/j.jhep.2010.06.004"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Ahn SY, Park SY, Tak WY, et al. Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension. Hepatology 61: 1033-1040, 2015.","DOI":"10.1002\/hep.27441"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hsu CC, Dodge JL, Weinberg E, et al. Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis. Hepatology 77: 1253-1262, 2023.","DOI":"10.1097\/HEP.0000000000000267"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nobel YR, Boike JR, Mazumder NR, et al.; Advancing Liver Therapeutic Approaches (ALTA) Study Group. Predictors of long-term clinical outcomes after TIPS: an ALTA group study. Hepatology 81: 1244-1255, 2025.","DOI":"10.1097\/HEP.0000000000001091"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chin A, Bastaich DR, Dahman B, Kaplan DE, Taddei TH, John BV. Refractory hepatic hydrothorax is associated with increased mortality with death occurring at lower MELD-Na compared to cirrhosis and refractory ascites. Hepatology 79: 844-856, 2024.","DOI":"10.1097\/HEP.0000000000000577"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Augustin S, Altamirano J, Gonz\u00e1lez A, et al. Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding. Am J Gastroenterol 106: 1787-1795, 2011.","DOI":"10.1038\/ajg.2011.173"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Buckholz A, Wong R, Curry MP, et al. MELD, MELD 3.0, versus Child score to predict mortality after acute variceal hemorrhage: a multicenter US cohort. Hepatol Commun 7: e0258, 2023.","DOI":"10.1097\/HC9.0000000000000258"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Ballmer PE, Walshe D, McNurlan MA, Watson H, Brunt PW, Garlick PJ. Albumin synthesis rates in cirrhosis: correlation with Child-Turcotte classification. Hepatology 18: 292-297, 1993.","DOI":"10.1002\/hep.1840180211"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bettinger D, Sturm L, Pfaff L, et al. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival. J Hepatol 74: 1362-1372, 2021.","DOI":"10.1016\/j.jhep.2021.01.023"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Singh SP, Maiwall R. MELD 3.0: a better score for liver allocation? Liver Transpl 29: 1017-1018, 2023.","DOI":"10.1097\/LVT.0000000000000180"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Yoo JJ, Chang JI, Moon JE, Sinn DH, Kim SG, Kim YS. Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation. Liver Transpl 29: 1029-1040, 2023.","DOI":"10.1097\/LVT.0000000000000126"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Abraldes JG, Caraceni P, Ghabril M, Garcia-Tsao G. Update in the treatment of the complications of cirrhosis. Clin Gastroenterol Hepatol 21: 2100-2109, 2023.","DOI":"10.1016\/j.cgh.2023.03.019"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Coemans M, Verbeke G, D\u00f6hler B, S\u00fcsal C, Naesens M. Bias by censoring for competing events in survival analysis. Br Med J 378: e071349, 2022.","DOI":"10.1136\/bmj-2022-071349"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hu K, Sedki M, Kwong A, et al.; Advancing Liver Therapeutic Approaches (ALTA) Study Group. Portal hypertensive gastropathy and MELD-Na score predict recurrent gastrointestinal bleeding after TIPSS: an ALTA group study. Aliment Pharmacol Ther 61: 346-353, 2025.","DOI":"10.1111\/apt.18362"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kang SH, Lee M, Kim MY, et al. The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study. Hepatol Int 15: 424-436, 2021.","DOI":"10.1007\/s12072-021-10160-3"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/3\/65_5556-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:46:50Z","timestamp":1770436010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/3\/65_5556-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5556-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"article-number":"5556-25"}}